{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T08:10:45Z","timestamp":1748333445700,"version":"3.37.3"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81603180","81670768","81670244","81570347","81470565","81503123"],"award-info":[{"award-number":["81603180","81670768","81670244","81570347","81470565","81503123"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LR16H310001"],"award-info":[{"award-number":["LR16H310001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.bbadis.2017.09.026","type":"journal-article","created":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T14:45:57Z","timestamp":1506696357000},"page":"252-262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Inhibition of myeloid differentiation factor-2 attenuates obesity-induced cardiomyopathy and fibrosis"],"prefix":"10.1016","volume":"1864","author":[{"given":"Qilu","family":"Fang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yali","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lintao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weixin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jibo","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2017.09.026_bb0005","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/jama.2014.732","article-title":"Prevalence of childhood and adult obesity in the United States, 2011\u20132012","volume":"311","author":"Ogden","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.bbadis.2017.09.026_bb0010","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc1408","article-title":"Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms","volume":"4","author":"Calle","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbadis.2017.09.026_bb0015","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0735-1097(02)02051-X","article-title":"Relationship between obesity, insulin resistance, and coronary heart disease risk","volume":"40","author":"Abbasi","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbadis.2017.09.026_bb0020","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1210\/jc.2004-0372","article-title":"Obesity, metabolic syndrome, and cardiovascular disease","volume":"89","author":"Grundy","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2017.09.026_bb0025","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa020245","article-title":"Obesity and the risk of heart failure","volume":"347","author":"Kenchaiah","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2017.09.026_bb0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12933-015-0234-z","article-title":"Cardiospecific CD36 suppression by lentivirus-mediated RNA interference prevents cardiac hypertrophy and systolic dysfunction in high-fat-diet induced obese mice","volume":"14","author":"Zhang","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bbadis.2017.09.026_bb0035","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.metabol.2015.04.010","article-title":"Chronic high fat diet induces cardiac hypertrophy and fibrosis in mice","volume":"64","author":"Wang","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.bbadis.2017.09.026_bb0040","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/clpt.2009.311","article-title":"Obesity, inflammation, and cardiovascular risk","volume":"87","author":"Mathieu","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bbadis.2017.09.026_bb0045","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1172\/JCI43378","article-title":"Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice","volume":"121","author":"Holland","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2017.09.026_bb0050","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1476-9255-9-48","article-title":"Elevated expression of the toll like receptors 2 and 4 in obese individuals: its significance for obesity-induced inflammation","volume":"9","author":"Ahmad","year":"2012","journal-title":"J. Inflamm. (Lond)"},{"key":"10.1016\/j.bbadis.2017.09.026_bb0055","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1172\/JCI28898","article-title":"TLR4 links innate immunity and fatty acid-induced insulin resistance","volume":"116","author":"Shi","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2017.09.026_bb0060","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/hrt.2002.007005","article-title":"Inflammatory mediators in chronic heart failure: an overview","volume":"90","author":"Anker","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.bbadis.2017.09.026_bb0065","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12950-015-0100-5","article-title":"Obesity-associated hypertension is ameliorated in patients with TLR4 single nucleotide polymorphism (SNP) rs4986790","volume":"12","author":"Schneider","year":"2015","journal-title":"J. Inflamm. (Lond)"},{"key":"10.1016\/j.bbadis.2017.09.026_bb0070","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1084\/jem.189.11.1777","article-title":"MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4","volume":"189","author":"Shimazu","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2017.09.026_bb0075","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/09680519000060050101","article-title":"Role of MD-2 in TLR2- and TLR4-mediated recognition of Gram-negative and Gram-positive bacteria and activation of chemokine genes","volume":"6","author":"Dziarski","year":"2000","journal-title":"J. Endotoxin Res."},{"key":"10.1016\/j.bbadis.2017.09.026_bb0080","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrmicro3047","article-title":"Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis","volume":"11","author":"Needham","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bbadis.2017.09.026_bb0085","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1111\/bph.13221","article-title":"MD-2 as the target of a novel small molecule, L6H21, in the attenuation of LPS-induced inflammatory response and sepsis","volume":"172","author":"Wang","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2017.09.026_bb0090","doi-asserted-by":"crossref","first-page":"G433","DOI":"10.1152\/ajpgi.00163.2009","article-title":"Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice","volume":"300","author":"Csak","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbadis.2017.09.026_bb0095","doi-asserted-by":"crossref","first-page":"8110","DOI":"10.1021\/jm200946h","article-title":"Evaluation and discovery of novel synthetic chalcone derivatives as anti-inflammatory agents","volume":"54","author":"Wu","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbadis.2017.09.026_bb0100","doi-asserted-by":"crossref","first-page":"535918","DOI":"10.1155\/2010\/535918","article-title":"Inflammation, a link between obesity and cardiovascular disease","volume":"2010","author":"Wang","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.bbadis.2017.09.026_bb0105","doi-asserted-by":"crossref","first-page":"13997","DOI":"10.1038\/ncomms13997","article-title":"Saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2","volume":"8","author":"Wang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2017.09.026_bb0110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.yjmcc.2015.02.029","article-title":"EGFR inhibition protects cardiac damage and remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model","volume":"82","author":"Liang","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2017.09.026_bb0115","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1124\/jpet.115.222570","article-title":"Curcumin analog L48H37 prevents lipopolysaccharide-induced TLR4 signaling pathway activation and sepsis via targeting MD2","volume":"353","author":"Wang","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbadis.2017.09.026_bb0120","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1182\/blood-2003-04-1290","article-title":"Soluble MD-2 activity in plasma from patients with severe sepsis and septic shock","volume":"104","author":"Pugin","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2017.09.026_bb0125","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/jama.2013.2194","article-title":"Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial","volume":"309","author":"Opal","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.bbadis.2017.09.026_bb0130","doi-asserted-by":"crossref","first-page":"568396","DOI":"10.1155\/2010\/568396","article-title":"Toll-like receptor 4 modulation as a strategy to treat sepsis","volume":"2010","author":"Wittebole","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.bbadis.2017.09.026_bb0135","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cmet.2012.04.006","article-title":"Lipid metabolism and toxicity in the heart","volume":"15","author":"Goldberg","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2017.09.026_bb0140","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.plefa.2011.04.018","article-title":"High fat diet induced diabetic cardiomyopathy","volume":"85","author":"Dirkx","year":"2011","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.bbadis.2017.09.026_bb0145","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1161\/01.RES.0000264104.25265.b6","article-title":"CD36 deficiency rescues lipotoxic cardiomyopathy","volume":"100","author":"Yang","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2017.09.026_bb0150","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1161\/CIRCULATIONAHA.107.712901","article-title":"CD36 expression contributes to age-induced cardiomyopathy in mice","volume":"116","author":"Koonen","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2017.09.026_bb0155","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.bbrc.2016.01.126","article-title":"MD-2 binds cholesterol","volume":"470","author":"Choi","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2017.09.026_bb0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00395-016-0599-5","article-title":"MD2 mediates angiotensin II-induced cardiac inflammation and remodeling via directly binding to Ang II and activating TLR4\/NF-kappaB signaling pathway","volume":"112","author":"Han","year":"2017","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.bbadis.2017.09.026_bb0165","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/01.RES.81.4.627","article-title":"Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha","volume":"81","author":"Kubota","year":"1997","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2017.09.026_bb0170","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1161\/CIRCULATIONAHA.106.643585","article-title":"Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state","volume":"115","author":"Sun","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2017.09.026_bb0175","first-page":"H1713","article-title":"Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner","volume":"260","author":"Ikeda","year":"1991","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.bbadis.2017.09.026_bb0180","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0002-9149(96)00063-X","article-title":"Circulating interleukin-6 in severe heart failure","volume":"79","author":"MacGowan","year":"1997","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.bbadis.2017.09.026_bb0185","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/75037","article-title":"TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice","volume":"6","author":"Zhang","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2017.09.026_bb0190","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.bbadis.2013.07.023","article-title":"Regulation of fetal gene expression in heart failure","volume":"1832","author":"Dirkx","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2017.09.026_bb0195","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.yjmcc.2013.11.005","article-title":"oxLDL induces inflammatory responses in vascular smooth muscle cells via urokinase receptor association with CD36 and TLR4","volume":"66","author":"Kiyan","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2017.09.026_bb0200","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00043798-199604000-00014","article-title":"Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies","volume":"3","author":"Hokanson","year":"1996","journal-title":"J. Cardiovasc. Risk"},{"key":"10.1016\/j.bbadis.2017.09.026_bb0205","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s00125-006-0340-2","article-title":"Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes","volume":"49","author":"Matikainen","year":"2006","journal-title":"Diabetologia"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443917303526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443917303526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T20:14:21Z","timestamp":1546287261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443917303526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0925443917303526"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2017.09.026","relation":{},"ISSN":["0925-4439"],"issn-type":[{"type":"print","value":"0925-4439"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of myeloid differentiation factor-2 attenuates obesity-induced cardiomyopathy and fibrosis","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2017.09.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}